Works about RADIOIMMUNOTHERAPY


Results: 573
    1
    2
    3
    4
    5
    6
    7

    Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [ 211 At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care.

    Published in:
    Cancers, 2025, v. 17, n. 7, p. 1190, doi. 10.3390/cancers17071190
    By:
    • Rousseau, Caroline;
    • Baumgartner, Pierre;
    • Heymann, Marie-Françoise;
    • Taupin, Manon;
    • Geffroy, Maïwenn;
    • Chatal, Jean-François;
    • Gautier, Gaëlle;
    • Allam, Nadia;
    • Gaschet, Joëlle;
    • Eychenne, Romain;
    • Guérard, François;
    • Gestin, Jean-François;
    • Varmenot, Nicolas;
    • Chérel, Michel
    Publication type:
    Article
    8
    9

    Radioimmunotheragnosis in Cancer Research.

    Published in:
    Cancers, 2024, v. 16, n. 16, p. 2896, doi. 10.3390/cancers16162896
    By:
    • Garaulet, Guillermo;
    • Báez, Bárbara Beatriz;
    • Medrano, Guillermo;
    • Rivas-Sánchez, María;
    • Sánchez-Alonso, David;
    • Martinez-Torrecuadrada, Jorge L.;
    • Mulero, Francisca
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111 In)/Yttrium 90 (90 Y) Ibritumomab Tiuxetan (Zevalin ®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2828, doi. 10.3390/cancers13112828
    By:
    • Wahl, Richard L.;
    • Frey, Eric C.;
    • Jacene, Heather A.;
    • Kahl, Brad S.;
    • Piantadosi, Steven;
    • Bianco, Jesus A.;
    • Hammes, Richard J.;
    • Jung, Miah;
    • Kasecamp, Wayne;
    • He, Bin;
    • Sgouros, George;
    • Flinn, Ian W.;
    • Swinnen, Lode J.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    CD46 targeted <sup>212</sup>Pb alpha particle radioimmunotherapy for prostate cancer treatment.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02636-x
    By:
    • Li, Jun;
    • Huang, Tao;
    • Hua, Jun;
    • Wang, Qiong;
    • Su, Yang;
    • Chen, Ping;
    • Bidlingmaier, Scott;
    • Li, Allan;
    • Xie, Zhongqiu;
    • Bidkar, Anil P.;
    • Shen, Sui;
    • Shi, Weibin;
    • Seo, Youngho;
    • Flavell, Robert R.;
    • Gioeli, Daniel;
    • Dreicer, Robert;
    • Li, Hui;
    • Liu, Bin;
    • He, Jiang
    Publication type:
    Article
    41
    42
    43
    44

    A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.

    Published in:
    PEDS: Protein Engineering, Design & Selection, 2013, v. 26, n. 3, p. 187, doi. 10.1093/protein/gzs096
    By:
    • Yazaki, Paul J.;
    • Lee, Brian;
    • Channappa, Divya;
    • Cheung, Chia-Wei;
    • Crow, Desiree;
    • Chea, Junie;
    • Poku, Erasmus;
    • Li, Lin;
    • Andersen, Jan Terje;
    • Sandlie, Inger;
    • Orcutt, Kelly Davis;
    • Wittrup, K.Dane;
    • Shively, John E.;
    • Raubitschek, Andrew;
    • Colcher, David
    Publication type:
    Article
    45

    A modular IgG-scFv bispecific antibody topology.

    Published in:
    PEDS: Protein Engineering, Design & Selection, 2010, v. 23, n. 4, p. 221, doi. 10.1093/protein/gzp077
    By:
    • Orcutt, Kelly Davis;
    • Ackerman, Margaret E.;
    • Cieslewicz, Maryelise;
    • Quiroz, Emmanuel;
    • Slusarczyk, Adrian L.;
    • Frangioni, John V.;
    • Wittrup, K. Dane
    Publication type:
    Article
    46
    47
    48
    49
    50